The ROA (Return on Assets) of Zentalis Pharmaceuticals Inc (ZNTL) is -38.54%.
ROA (Return on Assets) calculates how much net income a company earns relative to its total assets. It reveals how efficiently a business is managing its resources.
| Date | Value |
|---|---|
| 2024-12-31 | -38.54% |
| 2023-12-31 | -52.96% |
| 2022-12-31 | -43.91% |
| 2021-12-31 | -34.92% |
| 2020-12-31 | -32.23% |
| 2019-12-31 | -52.18% |
| 2018-12-31 | -51.39% |